ÉϺ£Í¬Ö¾ - ÉϺ£Í¬Ö¾ÁÄÌìÊÒ - ÉϺ£Í¬Ö¾½»ÓÑ - Mollis Shanghai UniClub

ÉϺ£Í¬Ö¾ - ÉϺ£Í¬Ö¾ÁÄÌìÊÒ - ÉϺ£Í¬Ö¾½»ÓÑ

 ÕÒ»ØÃÜÂë
 »¶Ó­¼ÓÈë һͬ×ÊѶ
http://www.danlan.org/new/UploadFile/201712/20171214/ea_20
http://www.danlan.org/new/UploadFile/201712/20171201/ea_20171211
http://www.danlan.org/new/UploadFile/20170
http://www.danlan.org/new/UploadFile/201712/20171212/ea_20171212221732992.jpg ɽÎ÷Ê¡ÎÀÉú¼

ABIVAX¹«²¼ÔÚÑп¹°¬Ò©×îÐÂÊý¾Ý

2018-7-19 09:36| ·¢²¼Õß: admin| ²é¿´: 831| ÆÀÂÛ: 0

ÕªÒª: ¡¡ABIVAXÔÚ°¬×Ì£¦¸ÎÑ×´ó»áÉϹ«²¼ÔÚÑÐÐÂÒ©ABX464×îÐÂÊý¾Ý¡¡¡¡¡¾ºÓ±±Í¬Ö¾»áËù¡¿×¨×¢ÓÚÀûÓÃÃâÒßϵͳ¿ª·¢¹¦ÄÜÐÔÖÎÓú°¬×̲¡²¡¶¾ÒÔ¼°ÖÎÁÆÑ×Ö¢/×ÔÉíÃâÒßÐÔ¼²²¡ºÍ°©Ö¢µÄÉúÎï¿Æ¼¼¹«Ë¾ABIVAX½üÆÚ¹«²¼Á˹«Ë¾ÔÚÑа¬×ÌÐÂÒ©ABX464 ...

¡¡

ABIVAXÔÚ°¬×Ì£¦¸ÎÑ×´ó»áÉϹ«²¼ÔÚÑÐÐÂÒ©ABX464×îÐÂÊý¾Ý

¡¡¡¡¡¾ºÓ±±Í¬Ö¾»áËù¡¿

רעÓÚÀûÓÃÃâÒßϵͳ¿ª·¢¹¦ÄÜÐÔÖÎÓú°¬×̲¡²¡¶¾ÒÔ¼°ÖÎÁÆÑ×Ö¢/×ÔÉíÃâÒßÐÔ¼²²¡ºÍ°©Ö¢µÄÉúÎï¿Æ¼¼¹«Ë¾ABIVAX½üÆÚ¹«²¼Á˹«Ë¾ÔÚÑа¬×ÌÐÂÒ©ABX464µÄ×îÐÂÊý¾Ý¡£ABX464ÊÇABIVAXÁìÏȵÄÁÙ´²ºòÑ¡²úÆ·£¬Ä¿Ç°ÕýÔÚ½øÐÐPhase 2ÆÚÁÙ´²ÊÔÑé¡£

¡¡¡¡´Ë´Î¹«²¼µÄÊý¾ÝÊÇÓйØABX464µÄ×÷ÓûúÖÆµÄ±íÏÖ¡£ÔÚÒâ´óÀûÂÞÂíRoma Eventi - Fontana di Trevi»áÒéÖÐÐľÙÐеÄÅ·ÖÞµÚ16½ì°¬×̲¡Óë¸ÎÑ×ÖÎÁƲßÂԺͿ¹²¡¶¾Ò©ÎïÄÍÒ©»áÒé(The 16th European Meeting on HIV & Hepatitis - Treatment Strategies & Antiviral Drug Resistance)ÉÏ£¬ABIVAX½éÉÜÁËABX464ÔÚHIVºÍÀ£ÑñÐԽ᳦Ñ×ÖеÄ×÷ÓûúÖÆ£¬ÒÔ¼°ABX464ÔÚHIVÖеÄÁÙ´²ÊÔÑéµÄ×îнøÕ¹¡£

¡¡¡¡ÐµÄÊý¾ÝÏÔʾABX464Óëñ×Ó½áºÏ¸´ºÏÌå(cap-binding complex, CBC)½áºÏ£¬´Ó¶øÔöÇ¿ÁËÁ½ÖÖRNAµÄ¼ô½Ó£º1. HIV¸´ÖÆËùÐèµÄ²¡¶¾RNAƬ¶Î£¬´Ó¶øÒÖÖÆ¸´ÖÆ£»2. ³¤µÄ·Ç±àÂëÈËRNA£¬ÆäÔÚ¼ô½Óºóµ¼ÖÂmiR124µÄ±í´ïÔö¼Ó£¬miR124ÊǾßÓÐǿЧ¿¹Ñ×ÌØÐÔµÄСmicroRNA¡£ÓÉÓÚÔö¼ÓµÄ¼ô½ÓÏÔʾ²úÉúеIJ¡¶¾RNAÖÖÀ࣬Õâ¿ÉÄÜÒý·¢HIV¸ÐȾϸ°ûµÄÃâÒßʶ±ð¡£

¡¡¡¡¡°ÕâЩ×îнá¹û½âÊÍÁËΪʲôABX464¿Éͨ¹ýÆä¿¹²¡¶¾ºÍ¿¹Ñ×ÌØÐÔÌá¹©Ë«ÖØ¿¹HIVЧ¹û¡£´ËÍ⣬½áºÏ¹Û²ìµ½µÄÐÂRNAÖÖÀàµÄ´æÔÚ£¬ËüÃÇΪÎÒÃÇÔÚHIVÁìÓòÊ×´ÎÖ¤Ã÷ÎÒÃÇ֮ǰµÄÁÙ´²ÊÔÑéÖй۲쵽HIV²¡¶¾¿â¼õÉÙÌṩÁËÁîÈËÐÅ·þµÄÀíÓÉ£¬¡±ABIVAX¹«Ë¾CEO Hartmut Ehrlich²©Ê¿±íʾ£¬¡°Í¨¹ýABX464ÖÎÁÆ´¥·¢miR124±í´ïÊÇÒ»ÖÖÐÂÓ±¶øÓÐȤµÄ»úÖÆ£¬ÎÒÃÇÒ²ÊǸոտªÊ¼Àí½â¡£Ðí¶à¿ÆÑ§¼ÒÔÚÑо¿ÖÐÒѾ­È·¶¨miR124µÄÉϵ÷ÊÇ¿ÉÒÔ×÷Ϊһ¸öÁîÈËÐ˷ܵÄÖÎÁưе㣬¾ßÓÐÖÎÁƶàÖÖÒÔÑ×֢ΪÖ÷ÒªÁÙ´²±íÏÖµÄÊÊÓ¦Ö¢µÄDZÁ¦¡£ÕâЩÊý¾Ý½øÒ»²½Ö§³ÖÁËÎÒÃÇÕýÔÚ½øÐеÄABX464ÖÎÁÆÀ£ÑñÐԽ᳦Ñ×µÄPhase 2aÆÚ¸ÅÄîÑéÖ¤Ñо¿£¬²¢Ö§³Ö¿ªÕ¹ÆäËûÊÊÓ¦Ö¢µÄÑо¿¡£¡±

¡¡¡¡Éî¶È²âÐòÊý¾ÝÏÔʾ£¬ÔöÇ¿µÄ¼ô½Ó²úÉúÒ»ÖÖÐÂÐÎʽµÄ¼ô½Ó²¡¶¾RNA£¬¿ÉÄÜDZÔÚµØÒý·¢HIV²¡¶¾¿âÖÐHIV¸ÐȾϸ°ûµÄÃâÒßʶ±ð¡£ÌṩµÄÊý¾Ý»¹Ö¤Ã÷ÁËABX464ÔöÇ¿Á˵¥¸ö³¤µÄ·Ç±àÂëÈËRNAµÄ±í´ïºÍ¼ô½Ó£¬ÔÚÀëÌåºÍHIV»¼ÕßÖвúÉú¿¹Ñ×miR124¡£¼øÓÚmiR124ÔÚÑ×Ö¢ÖÐÉϵ÷µÄ¹Ø¼ü×÷Óã¬ÒÔ¼°ABX464ͨ¹ýÔöÇ¿¼ô½Ó²úÉúÐÂÐͲ¡¶¾RNAºÍmiR-124µÄÄÜÁ¦£¬ÕâЩ½á¹ûÌṩ֤¾Ý±íÃ÷ABX464°ÐÏòCBC¿ÉÄÜÊÇʵÏÖ¹¦ÄÜÐÔHIVÖÎÓúÒÔ¼°ÖÎÁÆÑ×ÐÔ¼²²¡µÄ·½·¨¡£

¡¡¡¡ABIVAX¹«Ë¾Ê×ϯҽѧ¹ÙJean-Marc Steens²©Ê¿Ò²¾ÍABX464ÔÚ°¬×̲¡»¼ÕßÖнøÐеÄPhase 2ÆÚÁÙ´²Ñо¿½á¹û½øÐÐÁ˸üУ¬ËûµÄ×ÛÊöº­¸ÇÁ½¸öÒÑÍê³ÉµÄPhase 2aÆÚÁÙ´²Ñо¿(ABX464-004ºÍABX464-005µÄµÚÒ»¸ö¶ÓÁÐ)£¬¸ÃÑо¿¶ÀÁ¢Ö¤ÊµABX464ÔÚʹÓÿ¹Äæ×ªÂ¼²¡¶¾Ò©Îï½ö28Ììºó£¬¿ÉÒÔ½«º¬ÓÐHIV DNAµÄ²¡¶¾¿âϸ°û¼õÉٸߴï50£¥¡£(×÷ÕߣºÂÔÏþѦ)

¡¡¡¡(À´Ô´£ºÒ»ÅµÒ½Ñ§)


ÏÊ»¨

ÎÕÊÖ

À×ÈË

·¹ý

¼¦µ°

×îÐÂÆÀÂÛ

Archiver|ÊÖ»ú°æ|СºÚÎÝ|ÉϺ£Í¬Ö¾ - ÉϺ£Í¬Ö¾ÁÄÌìÊÒ - ÉϺ£Í¬Ö¾½»ÓÑ  

GMT+8, 2023-1-27 12:15 , Processed in 0.080005 second(s), 19 queries .

Powered by ͬ־´óȫվ¶ÔÓÚÈκΰüº¬ÓÚ¡¢¾­ÓÉ¡¢Á´½Ó¡¢ÏÂÔØ»ò´ÓÈκÎÓë±¾ÍøÕ¾ÓйطþÎñ£¨ÒÔϼò³Æ[·þÎñ]£©Ëù»ñµÃ µÄÐÅÏ¢¡¢ÄÚÈÝ»ò¹ã¸æ£¨ÒÔϼò³Æ[×ÊÁÏ]£©£¬²»ÉùÃ÷»ò±£Ö¤ÆäÕýÈ·ÐÔ»ò¿É¿¿ÐÔ¡£ÄúÓڴ˽ÓÊܲ¢³ÐÈÏÐÅÀµÈκΠ[×ÊÁÏ]Ëù·¢ÉúµÄ·çÏÕ¶¼Ó¦×ÔÐге£¡£¶ÔÓÚÒò[·þÎñ]¡¢[×ÊÁÏ]ËùÉúµÄÈκÎÖ±½Ó¡¢¼ä½Ó¡¢¸½´øµÄ»òÒò´Ë¶øµ¼Ö µÄÑÜÉúÐÔËðʧ¸Å²»¸ºÔð¡£ °²»ÕÍ¬Ö¾ÍøÕ¾ÎªÃâ·ÑÍøÖ·Õ¾£¬ËùÓÐÁ¬½Ó¾ùÀ´×ÔÍøÉÏ£¬ÆäÏà¹ØÄÚÈÝÒ»¸ÅÓë±¾Õ¾Î޹أ¬±¾Õ¾²»¶ÔÏà¹ØÍøÕ¾ÄÚÈÝ ¸ºÔð£¡ÈçÄú·¢ÏÖ±¾Õ¾ÓÐÈκηǷ¨²»Á¼Á¬½Ó,ÇëÁ¢¼´¸æÖ®ÎÒÃÇ,ÎÒÃǽ«ÔÚµÚһʱ¼äÄÚɾ³ý.ÎÒÃǼá¾öÖ§³ÖºÍÅä ºÏרÏîÐж¯ X3.2

© 2001-2013 Comsenz Inc.

·µ»Ø¶¥²¿